Scribe Therapeutics Inc. (SCTX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$16.58

From 52W high−54.95%

Volume263055.00

Market cap$317.67M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$16.58

From 52W high

−54.95%

Volume

263055.00

Market cap

$317.67M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

42.2

MomentumView details →

1D Return

+3.58%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+3.58%

YTD Return

—

1Y Return

—

RSI (14)

42.2

vs 50D SMA

−27.56%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.62

EPS Surprise

27.62%

Beats (12Q)

1/12

Next Q EPS Est

—

Avg Surprise (4Q)

27.62%

Rev Surprise

−38.91%

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for SCTX.

Similar companies

Kyverna Therapeutics, Inc.KYTX Agenus Inc.AGEN X4 Pharmaceuticals, Inc.XFOR Benitec Biopharma Inc.BNTC Transcenta Holding Limited06628.HK Enanta Pharmaceuticals, Inc.ENTA Find similar companies →

Latest newsMore news →

No recent news for SCTX.